| NSAIDs and COVID-19: a systematic review and meta-analysis N Moore, P Bosco-Levy, N Thurin, P Blin, C Droz-Perroteau Drug safety 44 (9), 929-938, 2021 | 87 | 2021 |
| Methods for safety signal detection in healthcare databases: a literature review M Arnaud, B Bégaud, N Thurin, N Moore, A Pariente, F Salvo Expert opinion on drug safety 16 (6), 721-732, 2017 | 86 | 2017 |
| Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using … CA Salinas, A Louder, J Polinski, TC Zhang, H Bower, S Phillips, Y Song, ... Rheumatology and Therapy 10 (1), 201-223, 2023 | 81 | 2023 |
| From inception to ConcePTION: genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding NH Thurin, R Pajouheshnia, G Roberto, C Dodd, G Hyeraci, C Bartolini, ... Clinical Pharmacology & Therapeutics 111 (1), 321-331, 2022 | 48 | 2022 |
| Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases-an ACCESS cohort study C Willame, C Dodd, CE Durán, R Elbers, R Gini, C Bartolini, O Paoletti, ... Vaccine 41 (1), 251-262, 2023 | 46 | 2023 |
| Epidemiology of metastatic castration-resistant prostate cancer: a first estimate of incidence and prevalence using the French nationwide healthcare database NH Thurin, M Rouyer, M Gross-Goupil, X Rebillard, M Soulié, T Haaser, ... Cancer Epidemiology 69, 101833, 2020 | 25 | 2020 |
| Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System N Moore, S Duret, A Grolleau, R Lassalle, V Barbet, M Duong, N Thurin, ... Drug Safety 42, 559-572, 2019 | 16 | 2019 |
| Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study M Raethke, F van Hunsel, N Luxi, T Lieber, C Bellitto, E Mulder, ... Vaccine 42 (9), 2357-2369, 2024 | 13 | 2024 |
| Cohort event monitoring of adverse reactions to COVID-19 vaccines in seven European Countries: pooled results on first dose M Raethke, F van Hunsel, NH Thurin, C Dureau-Pournin, D Mentzer, ... Drug Safety 46 (4), 391-404, 2023 | 13 | 2023 |
| Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data NH Thurin, P Bosco-Levy, P Blin, M Rouyer, J Jové, S Lamarque, S Lignot, ... BMC Medical Research Methodology 21 (1), 95, 2021 | 13 | 2021 |
| Towards an interoperable ecosystem of research cohort and real-world data catalogues enabling multi-center studies M Swertz, E van Enckevort, JL Oliveira, I Fortier, J Bergeron, NH Thurin, ... Yearbook of medical informatics 31 (01), 262-272, 2022 | 11 | 2022 |
| Empirical assessment of case‐based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project NH Thurin, R Lassalle, M Schuemie, M Pénichon, JJ Gagne, JA Rassen, ... Pharmacoepidemiology and Drug Safety 29 (9), 993-1000, 2020 | 11 | 2020 |
| Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data G Gandaglia, F Pellegrino, A Golozar, B De Meulder, T Abbott, A Achtman, ... European Urology 85 (5), 457-465, 2024 | 9 | 2024 |
| National Health Insurance Claims Database in France (SNIRAM), Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH) N Moore, P Blin, R Lassalle, N Thurin, P Bosco-Levy, C Droz Databases for Pharmacoepidemiological Research, 131-140, 2021 | 9 | 2021 |
| Safety of COVID-19 vaccines among the paediatric population: analysis of the European surveillance systems and pivotal clinical trials F Ahmadizar, N Luxi, M Raethke, S Schmikli, F Riefolo, PW Saraswati, ... Drug Safety 46 (6), 575-585, 2023 | 7 | 2023 |
| Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database NH Thurin, M Rouyer, J Jové, M Gross-Goupil, T Haaser, X Rébillard, ... Expert Review of Clinical Pharmacology 15 (9), 1139-1145, 2022 | 6 | 2022 |
| Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study F Ciccimarra, N Luxi, C Bellitto, L L’Abbate, M Raethke, F van Hunsel, ... Vaccines 12 (3), 241, 2024 | 4 | 2024 |
| Empirical assessment of case‐based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS) NH Thurin, R Lassalle, M Schuemie, M Pénichon, JJ Gagne, JA Rassen, ... Pharmacoepidemiology and Drug Safety 29 (8), 890-903, 2020 | 4 | 2020 |
| What Is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “COVID Vaccine Monitor” Active Surveillance Study C Bellitto, N Luxi, F Ciccimarra, L L’Abbate, M Raethke, F van Hunsel, ... Drug Safety 47 (10), 1011-1023, 2024 | 3 | 2024 |
| Clustering of prostate cancer healthcare pathways in the French National Healthcare database R Baulain, J Jové, D Sakr, M Gross‐Goupil, M Rouyer, M Puel, P Blin, ... Cancer Innovation 2 (1), 52-64, 2023 | 3 | 2023 |
